(Q58478202)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18466046%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

0 references

1 reference

title

Diagnostic and prognostic needs in neurodegenerative disorders: focus on proteomics (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18466046%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

0 references

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18466046%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

author name string

Mirko Bibl

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18466046%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

publication date

1 April 2008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18466046%20AND%20SRC:MED&resulttype=core&format=json

Expert Review of Proteomics

7 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18466046%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

volume

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18466046%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18466046%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

page(s)

153-156

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18466046%20AND%20SRC:MED&resulttype=core&format=json

Therapeutic approaches to Alzheimer's disease

7 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1586%2F14789450.5.2.153

Diagnostic criteria for neuropathologic assessment of Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.5.2.153

Alzheimer's disease and Down's syndrome: Sharing of a unique cerebrovascular amyloid fibril protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.5.2.153

Microtubule-associated protein tau (tau) is a major antigenic component of paired helical filaments in Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.5.2.153

Detection of tau proteins in normal and Alzheimer's disease cerebrospinal fluid with a sensitive sandwich enzyme-linked immunosorbent assay.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.5.2.153

Tau protein in cerebrospinal fluid: a biochemical marker for axonal degeneration in Alzheimer disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.5.2.153

Reduction of beta-amyloid peptide42 in the cerebrospinal fluid of patients with Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.5.2.153

Consensus Report of the Working Group on: “Molecular and Biochemical Markers of Alzheimer’s Disease” 11The names of the Working Group Members and the names of the Working Group Advisory Committee Members are listed in the Appendix A(section VI)

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.5.2.153

Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS-ADRDA criteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.5.2.153

Cerebrospinal fluid protein biomarkers for Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.5.2.153

Combination assay of CSF tau, A beta 1-40 and A beta 1-42(43) as a biochemical marker of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.5.2.153

Biochemical diagnosis of Alzheimer disease by measuring the cerebrospinal fluid ratio of phosphorylated tau protein to beta-amyloid peptide42.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.5.2.153

Neurochemical diagnosis of Alzheimer's dementia by CSF Abeta42, Abeta42/Abeta40 ratio and total tau.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.5.2.153

Highly conserved and disease-specific patterns of carboxyterminally truncated Abeta peptides 1-37/38/39 in addition to 1-40/42 in Alzheimer's disease and in patients with chronic neuroinflammation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.5.2.153

CSF amyloid-beta-peptides in Alzheimer's disease, dementia with Lewy bodies and Parkinson's disease dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.5.2.153

CSF diagnosis of Alzheimer's disease and dementia with Lewy bodies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.5.2.153

Reduced CSF carboxyterminally truncated Aβ peptides in frontotemporal lobe degenerations

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.5.2.153

Validation of amyloid-beta peptides in CSF diagnosis of neurodegenerative dementias.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.5.2.153

Association between CSF biomarkers and incipient Alzheimer's disease in patients with mild cognitive impairment: a follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.5.2.153

Amyloid beta peptide ratio 42/40 but not A beta 42 correlates with phospho-Tau in patients with low- and high-CSF A beta 40 load.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.5.2.153

Plasma Abeta(1-40) and Abeta(1-42) and the risk of dementia: a prospective case-cohort study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.5.2.153

Blood-based neurochemical diagnosis of vascular dementia: a pilot study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.5.2.153

Classification and prediction of clinical Alzheimer's diagnosis based on plasma signaling proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.5.2.153

The German Competence Net Dementias: standard operating procedures for the neurochemical dementia diagnostics

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.5.2.153

International quality control survey of neurochemical dementia diagnostics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.5.2.153

21 January 2018

Identifiers

DOI

10.1586/14789450.5.2.153

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18466046%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

1 reference